Evotec is particularly focused on expanding its biologics capabilities to meet increased demand for complex biologics manufacturing and broaden its offerings to customers. We expect the company will ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the addition of Patrick Daly as its Chief Business Officer as the company continues to expand its ...